
|Articles|February 3, 2005
Study may explain why prostate tumor cells become resistant to hormone therapy
Certain mutations in the androgen receptor protein appear to cause advanced and invasive prostate cancer, at least in a mouse model, according to a recent study in the Proceedings of the National Academy of Sciences (2005; 102:1151-6).
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
2
NDV-01 produces robust 9-month results in high-risk NMIBC
3
Choosing salvage therapy after prostate cancer focal ablation
4
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
5


















